Effect of the solvent on the green synthesis of NIR active polymeric nanoparticles and their in vitro photothermal therapeutic validation
Source abstract
Abstract
Abstract Nanoparticle-mediated drug delivery has revolutionized nano-therapeutics. It ensures improved biodistribution, longer blood circulation, and improved bioavailability inside the body. The loading efficiency and stability of the drug within the carrier are the major challenges for ideal drug delivery. In this study, we have synthesized indocyanine green (ICG) loaded Poly-L-Lysine (PLL) nanoparticles by a two-step self-assembly process using a green chemistry approach, where water-based solvents were used for fabrication such as phosphate-buffered saline (PBS, pH 7.4), deionized water (DI), and Milli-Q water (MQ). The effect of these solvents on the morphology, stability and loading efficiency of ICG was investigated using UV-visible spectroscopy, fluorescence spectroscopy, scanning electron microscopy, and dynamic light scattering. The results demonstrated that nanoparticles can be fabricated using all the three solvents, however, there was a huge difference between their functional and morphological properties. These functional and morphological properties play important role in their biomedical applications. It was found that PBS-based NPs showed the maximum loading of ICG followed by DI water and MQ water respectively. The PBS suspended ICG-loaded PLL nanoparticles were highly monodispersed with the mean diameter of ∼200 nm and showed highest photothermal efficiency. The green synthesized biocompatible and biodegradable NPs were designed to treat solid tumors via local hyperthermia due to photothermal property of these NPs. The photothermal cytotoxicity assessment of PBS-based PLL-ICG NPs in both 2D and 3D in vitro cultures displayed notable efficacy. Therefore, we conclusively demonstrate that selection of right solvent is crucial to realize the full potential of green-synthesized polymeric nanoparticles.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Nanoplatforms for cancer theranostics · Advanced Nanomaterials in Catalysis · Nanoparticle-Based Drug Delivery
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (51)
Show source-provided references
1. Cancer incidence estimates for 2022 & projection for 2025: result from National Cancer Registry Programme, India10.4103/ijmr.ijmr_1821_22 ↗
2. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries10.3322/caac.21834 ↗
3. Recent advances in breast cancer metastasis with special emphasis on metastasis to the brain10.1016/j.prp.2024.155378 ↗
4. Exploring treatment options in cancer: tumor treatment strategies10.1038/s41392-024-01856-7 ↗
5. Targeting cancer cells with nanotherapeutics and nanodiagnostics: current status and future perspectives10.1016/j.semcancer.2020.01.011 ↗
6. Nanomedicines for developing cancer nanotherapeutics: from benchtop to bedside and beyond10.1007/s00253-018-9352-3 ↗
7. Assessment of the evolution of cancer treatment therapies10.3390/cancers3033279 ↗
8. The role of surgery in metastatic bladder cancer: a systematic review10.1016/j.eururo.2017.09.030 ↗
9. A view on drug resistance in cancer10.1038/s41586-019-1730-1 ↗
10. Current prospects for treatment of solid tumors via photodynamic, photothermal, or ionizing radiation therapies combined with immune checkpoint inhibition (a review)10.3390/ph14050447 ↗
11. Gene-based strategies for the immunotherapy of cancer10.1007/s001090050133 ↗
12. Revolutionizing cancer care strategies: immunotherapy, gene therapy, and molecular targeted therapy10.1007/s11033-023-09096-8 ↗
13. The current status of gene therapy for the treatment of cancer10.2147/BTT.S302095 ↗
14. Elgazzar · 2006 · 540
15. Personalized treatment for patients with colorectal cancer: role of biomarkers10.2217/bmm.15.3 ↗
16. A comprehensive review on photodynamic therapy (PDT) and photothermal therapy (PTT) for cancer treatment10.5505/tjo.2020.2400 ↗
17. Recent progress on photodynamic therapy and photothermal therapy10.1002/bkcs.12655 ↗
18. Near-infrared photoactivated nanomedicines for photothermal synergistic cancer therapy10.1016/j.nantod.2020.101073 ↗
19. Towards effective photothermal/photodynamic treatment using plasmonic gold nanoparticles10.3390/ijms17081295 ↗
20. Assembly-enhanced indocyanine green nanoparticles for fluorescence imaging-guided photothermal therapy10.1039/D4TB01604A ↗
21. Indocyanine green delivery systems for tumour detection and treatments10.1016/j.biotechadv.2016.04.001 ↗
22. Indocyanine green-incorporating nanoparticles for cancer theranostics10.7150/thno.22872 ↗
23. Sentinel lymph node staging with indocyanine green for patients with cervical cancer: the safety and feasibility of open approach using SPY-PHI technique10.3390/jcm10214849 ↗
24. NIR fluorescence-guided tumor surgery: new strategies for the use of indocyanine green10.2147/IJN.S207486 ↗
25. Indocyanine green-based theranostic nanoplatform for NIR fluorescence image-guided chemo/photothermal therapy of cervical cancer10.2147/IJN.S318678 ↗
26. Opportunities and challenges of indocyanine green in gastrointestinal cancers for intraoperative and nano-medicine application10.1186/s12645-024-00251-9 ↗
27. Improving drug accumulation and photothermal efficacy in tumor depending on size of ICG loaded lipid-polymer nanoparticles10.1016/j.biomaterials.2014.04.019 ↗
28. Development of PLGA-lipid nanoparticles with covalently conjugated indocyanine green as a versatile nanoplatform for tumor-targeted imaging and drug delivery10.2147/IJN.S119999 ↗
29. Development of indocyanine green loaded Au@ Silica core shell nanoparticles for plasmonic enhanced light triggered therapy10.1016/j.jphotochem.2019.02.028 ↗
30. Efficient photoacoustic imaging using indocyanine green (ICG) loaded functionalized mesoporous silica nanoparticles10.1039/c9bm00822e ↗
31. One-pot fabrication of hollow porphyrinic MOF nanoparticles with ultrahigh drug loading toward controlled delivery and synergistic cancer therapy10.1021/acsami.0c20617 ↗
32. Research progress on self-assembled nanodrug delivery systems10.1039/d1tb02470a ↗
33. Improving cellular uptake of therapeutic entities through interaction with components of cell membrane10.1080/10717544.2019.1582730 ↗
34. Protease responsive essential amino-acid based nanocarriers for near-infrared imaging10.1038/s41598-019-56871-4 ↗
35. Polypyrrole nanoparticles loaded with doxorubicin for pH-responsive combinational photothermal-chemotherapy of cancer cells10.1063/5.0178702 ↗
36. Poly-l-lysine derivative-coated black phosphorus as a nanoplatform for photothermal chemotherapy to enhance anti-tumor efficiency10.1039/D1TB02456F ↗
37. A polylysine/hyaluronan-based core-shell nanoparticle triggers drug delivery by ATP/hyaluronidase dual stimuli for inducing apoptosis of breast cancer cells10.1016/j.ijbiomac.2024.134188 ↗
38. Temperature-sensitive gold nanoparticle-coated pluronic-PLL nanoparticles for drug delivery and chemo-photothermal therapy10.7150/thno.18832 ↗
39. Green chemistry approach for fabrication of polymer composites10.3390/suschem2020015 ↗
40. A study of the role of the solvent during magnetite nanoparticle synthesis: tuning size, shape and self-assembly10.1039/c2ra20494k ↗
41. Cyrene as solvent for metal nanoparticle synthesis10.1007/s11051-024-06097-x ↗
42. Two-photon excitation and direct emission from S2 state of FDA approved NIR dye: application of anti-Kasha’s rule for two-photon fluorescence imaging
43. Indocyanine green-loaded gold nanostars for sensitive SERS imaging and subcellular monitoring of photothermal therapy10.1039/C7NR02798B ↗
44. Effects of ionic strength on the size and compactness of chitosan nanoparticles10.1007/s00396-012-2604-3 ↗
45. Changes of water hydrogen bond network with different externalities10.3390/ijms16048454 ↗
46. Kosmotropes and chaotropes: modelling preferential exclusion, binding and aggregate stability10.1016/j.bpc.2004.06.012 ↗
47. Interparticle forces underlying nanoparticle self‐assemblies10.1002/smll.201501783 ↗
48. Nanoparticle colloidal stability in cell culture media and impact on cellular interactions10.1039/C4CS00487F ↗
49. A review of reagents for fluorescence microscopy of cellular compartments and structures, Part III: reagents for actin, tubulin, cellular membranes, and whole cell and cytoplasm10.1002/0471142956.cy1232s67 ↗
50. Methods to detect apoptotic cell death10.1007/s10495-016-1333-3 ↗
51. Photothermal and radiotherapy with alginate-coated gold nanoparticles for breast cancer treatment10.1038/s41598-024-60396-w ↗